Overview

Finasteride Treatment of Severe Nodulocystic Acne

Status:
Completed

Trial end date:
2017-06-06

Target enrollment:

Participant gender:

Summary

Double-blind, randomized, placebo-controlled, dose-ranging study to evaluate the efficacy and safety of once weekly, high dose oral finasteride compared to placebo for the treatment of severe nodulocystic acne in male subjects.

Phase:

Phase 2

Details

Lead Sponsor:

Elorac, Inc.

Treatments:

Finasteride